UPDATE: Morgan Stanley Reiterates On LifePoint Hospitals Following 3Q14 Report
In a report published Monday, Morgan Stanley analyst Andrew Schenker reiterated an Equal-Weight rating on LifePoint Hospitals (NASDAQ: LPNT), but removed the $76.00 price target.
In the report, Morgan Stanley noted, “Our updated 2015 EBITDA est. of $700M reflects improving utilization trends and reform. The quarter saw positive underlying reform metrics as LPNT saw greater SS self-pay declines vs. 2Q. Separately, volumes in the quarter improved with SS equivalent admissions up 4.5% Y/Y.”
LifePoint Hospitals closed on Friday at $70.73.
Latest Ratings for LPNT
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 2018 | Credit Suisse | Maintains | Neutral | Neutral |
| Jul 2018 | BMO Capital | Maintains | Market Perform | Market Perform |
| Jul 2018 | Baird | Downgrades | Outperform | Neutral |
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Andrew Schenker Morgan StanleyAnalyst Color Price Target Analyst Ratings
